Detalhe da pesquisa
1.
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
N Engl J Med
; 387(14): 1292-1302, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036522
2.
The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator.
J Cardiovasc Electrophysiol
; 35(2): 230-237, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047467
3.
Clinical Outcomes of Cardiac Resynchronization with Epicardial Left Ventricular Lead.
Pacing Clin Electrophysiol
; 38(10): 1201-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26172535
4.
Pocket infections of cardiac implantable electronic devices treated by negative pressure wound therapy.
Europace
; 16(3): 372-7, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24127355
5.
Prognostic significance of atrial arrhythmias in a primary prevention ICD population.
Pacing Clin Electrophysiol
; 34(9): 1070-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21605131
6.
Device infections: management and indications for lead extraction.
Circulation
; 128(9): 1031-8, 2013 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23979629
7.
Contribution of Cardiac Implantable Electronic Devices to Thrombus Formation in Patients With Chronic Thromboembolic Pulmonary Hypertension.
JACC Clin Electrophysiol
; 4(11): 1431-1436, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30466848
8.
Lead extractions: indications, procedural aspects, and outcomes.
Cardiol Clin
; 32(2): 201-10, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24793797
9.
Standard chest radiograph predicts left ventricular lead location in chronic resynchronization therapy patients more accurately than intraoperative fluoroscopy.
J Interv Card Electrophysiol
; 35(3): 323-30, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22843127
10.
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.
Heart Rhythm
; 14(12): e503-e551, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28919379
11.
Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
J Am Coll Cardiol
; 52(7): 541-50, 2008 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-18687248